Cipla Limited, a leading pharmaceutical player in India, announced a significant investment in its associate company, Achira Labs Private Limited. This strategic move underscores Cipla’s commitment to advancing Point-of-Care (PoC) diagnostic solutions in India. Strengthening the Partnership for Broader PoC Diagnostics Focus On May 15, 2024, Cipla entered into definitive agreements to invest up to …